INO EPS Estimates
Inovio Pharmaceuticals, Inc.
$1.51
+$0.29(+24.28%)
53
Overall
60
Value
66
Tech
34
Quality
Market Cap
$156.13M
Volume
31.14M
52W Range
$0.56 - $2.72
Target Price
$5.33
INO EPS estimates: the consensus estimate for Inovio Pharmaceuticals, Inc.'s current fiscal year is -$0.74 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
INO EPS Estimates
- EPS estimate, current quarter
- $-0.20
- EPS estimate, next quarter
- $-0.20
- EPS estimate, current year
- $-0.74
- EPS estimate, next year
- $-0.42
- EPS growth, 3-year
- +49.48%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.81 |
| 2024 | $-3.95 |
| 2023 | $-6.09 |
| 2022 | $-14.04 |
| 2021 | $-17.40 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INO | $1.51 | +24.3% | 31.14M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Inovio Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW